HOMOLOGY MEDICINES INC's ticker is FIXX and the CUSIP is 438083107. A total of 122 filers reported holding HOMOLOGY MEDICINES INC in Q4 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $327 | +32.4% | 280 | 0.0% | 0.00% | – |
| Q2 2023 | $247 | -86.1% | 280 | -83.8% | 0.00% | – |
| Q1 2023 | $1,780 | +78.0% | 1,729 | +75.5% | 0.00% | – |
| Q4 2022 | $1,000 | 0.0% | 985 | +5.3% | 0.00% | – |
| Q3 2022 | $1,000 | -50.0% | 935 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | -85.7% | 935 | -79.4% | 0.00% | – |
| Q1 2022 | $14,000 | -12.5% | 4,535 | +4.8% | 0.00% | – |
| Q4 2021 | $16,000 | -91.2% | 4,329 | -81.4% | 0.00% | – |
| Q3 2021 | $182,000 | +5.2% | 23,250 | -2.1% | 0.00% | – |
| Q2 2021 | $173,000 | -12.6% | 23,750 | +12.8% | 0.00% | – |
| Q1 2021 | $198,000 | -16.8% | 21,050 | -0.1% | 0.00% | -100.0% |
| Q4 2020 | $238,000 | +4.4% | 21,070 | -0.9% | 0.00% | 0.0% |
| Q3 2020 | $228,000 | -26.2% | 21,270 | +4.4% | 0.00% | 0.0% |
| Q2 2020 | $309,000 | -3.1% | 20,370 | -0.7% | 0.00% | 0.0% |
| Q1 2020 | $319,000 | – | 20,517 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 4,535,919 | $8,936,000 | 2.21% |
| Vida Ventures Advisors, LLC | 770,845 | $1,519,000 | 1.28% |
| OUP Management Co., LLC | 64,000 | $126,000 | 0.17% |
| Oasis Management Co Ltd. | 280,000 | $552,000 | 0.10% |
| Vivo Capital, LLC | 370,068 | $729,000 | 0.07% |
| AAF Wealth Management, LLC | 47,501 | $94,000 | 0.07% |
| TANG CAPITAL MANAGEMENT LLC | 214,898 | $423,000 | 0.06% |
| Temasek Holdings (Private) Ltd | 5,650,996 | $11,132,462 | 0.06% |
| Bellevue Group AG | 1,622,522 | $3,196,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 128,353 | $253,000 | 0.04% |